Dr Lucio Fumi, MD, is a European physician, who worked as a clinical geriatrician, and after
that for over thirty years in the healthcare industry in Italy, Germany, Slovenia, the UK and the
Netherlands. Registered for Medical Practice in Italy and the UK, Dr Fumi has worked as
Medical Director of international corporations, to include Baxter, Abbott, Terumo and Bristol-
Myers Squibb, with pharmaceutical, biotech, clinical nutrition and medical technology
products.
In 1998 Dr Fumi set up Wyfold Medical, a consultancy agency dedicated to medical affairs
and clinical development for the medical device and biotech industry. As interim manager, Dr
Fumi worked also as Medical Director or Chief Medical Officer of BioPheresis, RanD Biotech,
Astellas Pharma, Clasado Biosciences, and BTG. He is currently Global Director of Medical
Affairs of Piramal Critical Care.
In the last 10 years his main focus has been in the loco-regional treatment of cancer,
anaesthesia, intensive care and pain management. Dr Fumi has been President of the Italian
Medical Society of Great Britain (2014-16) and Chairman of the Board of BetaGlue
Technologies (2016-18). During the Covid-19 pandemic he has been involved in drug
repurposing projects and in the vaccination programme in the UK.